Beasley M R, Henry A M, Bestall J, Cosgrove V P, Murray L J, Burnett C
Radiotherapy, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, UK; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Leeds Institute of Medical Research, University of Leeds, Leeds, UK; Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, UK.
Radiography (Lond). 2025 Mar;31(2):102868. doi: 10.1016/j.radi.2025.01.003. Epub 2025 Jan 24.
Using non-medicinal oral contrast agents may aid safe delivery of magnetic resonance image-guided (MR-guided) radiotherapy by improving the ability to visualise and avoid excessive radiation dose to adjacent bowel/stomach. This scoping review aims to map the literature on non-medicinal oral contrasts used in upper-abdominal diagnostic or therapeutic magnetic resonance imaging (MRI) to find potential candidates for employing in MR-guided radiotherapy and identify gaps in knowledge for further study.
A scoping review of non-medicinal oral contrast used in upper-abdominal MRI research followed a pre-defined protocol based on Arksey and O'Malley's framework. Data were charted and reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Scoping Reviews reporting guidelines.
Forty-seven studies from 1955 screened abstracts were charted. Thirty-one distinct non-medicinal oral contrast were identified, used primarily to enhance tissue visualisation (89 %) or observe motility (11 %) in diagnostic studies. All studies reported to be predominantly quantitative; only 13 % included participant experience via questionnaires and none used qualitative methods. No studies have examined the efficacy of non-medicinal oral contrasts in MR-guided radiotherapy planning or delivery.
Non-medicinal oral contrasts have been extensively investigated in diagnostic MRI to enhance gastrointestinal visualisation and assess motility. However, non-medicinal oral contrasts have not been investigated in the context of radiotherapy planning and treatment. Qualitative evaluation of the patient experience of non-medicinal oral contrasts in magnetic resonance image-guided radiotherapy should be considered alongside studies quantifying the potential clinical benefit.
This review summarises the properties of non-medicinal oral contrasts and identifies critical gaps in the current evidence, particularly the absence of qualitative research in this domain and the unexplored potential for their application in MR-guided radiotherapy planning and delivery.
使用非药用口服造影剂可通过提高可视化能力并避免对邻近肠道/胃部的过量辐射剂量,有助于磁共振成像引导(MR引导)放疗的安全实施。本范围综述旨在梳理关于上腹部诊断或治疗性磁共振成像(MRI)中使用的非药用口服造影剂的文献,以寻找可用于MR引导放疗的潜在候选者,并确定有待进一步研究的知识空白。
对上腹部MRI研究中使用的非药用口服造影剂进行范围综述,遵循基于阿克西和奥马利框架的预定义方案。数据根据系统评价和Meta分析的首选报告项目(PRISMA-ScR)报告指南进行图表绘制和报告。
对1955篇筛选摘要中的47项研究进行了图表绘制。确定了31种不同的非药用口服造影剂,主要用于增强诊断研究中的组织可视化(89%)或观察蠕动(11%)。所有研究均报告主要为定量研究;只有13%通过问卷调查纳入了参与者的体验,且没有一项使用定性方法。尚无研究考察非药用口服造影剂在MR引导放疗计划或实施中的疗效。
非药用口服造影剂在诊断性MRI中已得到广泛研究,以增强胃肠道可视化并评估蠕动。然而,非药用口服造影剂在放疗计划和治疗方面尚未得到研究。在对非药用口服造影剂在磁共振成像引导放疗中的患者体验进行定性评估的同时,也应开展量化潜在临床益处的研究。
本综述总结了非药用口服造影剂的特性,并确定了当前证据中的关键空白,特别是该领域缺乏定性研究以及其在MR引导放疗计划和实施中的应用潜力尚未得到探索。